SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019970
Filing Date
2024-05-15
Accepted
2024-05-15 17:00:40
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 782248
2 ex31-1.htm EX-31.1 21492
3 ex31-2.htm EX-31.2 20947
4 ex32-1.htm EX-32.1 7196
5 ex32-2.htm EX-32.2 6600
6 form10-q_001.jpg GRAPHIC 15073
7 form10-q_002.jpg GRAPHIC 67927
8 form10-q_003.jpg GRAPHIC 15203
9 form10-q_004.jpg GRAPHIC 12417
10 form10-q_005.jpg GRAPHIC 86898
  Complete submission text file 0001493152-24-019970.txt   5355136

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE gtbp-20240331.xsd EX-101.SCH 38262
12 XBRL CALCULATION FILE gtbp-20240331_cal.xml EX-101.CAL 41119
13 XBRL DEFINITION FILE gtbp-20240331_def.xml EX-101.DEF 175332
14 XBRL LABEL FILE gtbp-20240331_lab.xml EX-101.LAB 324501
15 XBRL PRESENTATION FILE gtbp-20240331_pre.xml EX-101.PRE 266200
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 699343
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 24952295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)